TransMedics Group, Inc. (TMDX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 136.42 |
| Open | 139.00 |
| Bid | 136.17 x 200 |
| Ask | 136.69 x 200 |
| Day's Range | 132.32 - 141.05 |
| 52 Week Range | 36.42 - 144.23 |
| Volume | |
| Avg. Volume | 870,011 |
| Market Cap | 4.493B |
| Beta (5Y Monthly) | 1.87 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.34 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 119.20 |
GuruFocus.comInsider Sale: Director David Weill Sells Shares of TransMedics Group Inc (TMDX)
On May 29, 2024, David Weill, Director at TransMedics Group Inc (NASDAQ:TMDX), executed a sale of 1,193 shares of the company.
Simply Wall St.The 3.9% return this week takes TransMedics Group's (NASDAQ:TMDX) shareholders three-year gains to 460%
For us, stock picking is in large part the hunt for the truly magnificent stocks. Mistakes are inevitable, but a single...
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on May 14, 2024, TransMedics granted non-qualified stock options to purchase an aggregate of 18,320 shares of its common stock and an aggregate of 12,068 restricted stock units to 8 employees, each as a material inducement for each employee's entry into employment with TransMedics. The g
© 2024 Yahoo. All rights reserved.